ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag toxic shock immunology neuroscience

Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
The Human Touch
Kate Yandell | Aug 1, 2015 | 10 min read
Can mice with humanlike tissues better model drug effects in people?
Immune to Failure
Karen Hopkin | Feb 1, 2013 | 9 min read
With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.
From Scholars to Scientists
The Scientist Staff | Nov 21, 2004 | 6 min read
is assembled one of the most prestigious biomedical communities in the world.
Creative Expression: Mammalian Expression Vectors and Systems
Christopher Smith | Feb 1, 1998 | 7 min read
Date: February 2, 1998 Chart 1 Chart 2 Prokaryotic expression systems, reviewed in the September 1, 1997, issue of The Scientist were part of the early repertoire of research tools in molecular biology. Although the expression of recombinant protein in prokaryotes provided a means to develop other research tools (antibodies, for example ) and study basic aspects of biological function, the scope and depth of this research were limited, especially with regard to eukaryotic proteins. The de novo
Cell-Signaling A Cascade of Kinases, Phosphatases, and Cytokines
Deborah Noble | Jul 4, 1999 | 8 min read
Date: July 5, 1999Table of Cell Signaling Tools At today's research pace, new signaling mechanisms within and between cells are emerging not one by one but in a chain reaction. Each new discovery has strong implications for previously established models, sometimes overturning several assumptions at once. With such a large number of interacting systems--from cell adhesion to differentiation and apoptosis--and receptor pathways, keeping up with the wealth of cell-signaling research tools can be l
Turmoil Besets Wistar In Wake Of Koprowski's Ouster
Jean Wallace | Mar 1, 1992 | 10+ min read
The Wistar Institute in Philadelphia marks its 100th anniversary this year, but the mood at the nation's oldest independent biomedical research facility is hardly jubilant. The institute has been in turmoil for the last year, after the abrupt ouster of longtime director Hilary Koprowski, the famed virologist and immunologist who transformed Wistar from a dilapidated museum into a world-renowned research center. The commotion recently was stirred up further, when the 75-year-old Koprowski file
Ubiquitin-Mediated Proteolytic System Plays Diverse Roles in Human Disease
Douglas Steinberg | Jul 19, 1998 | 9 min read
A pharmaceutical milestone seems to have been reached last month when a National Cancer Institute panel approved an anti-tumor drug called PS-341 for government-financed clinical trials. PS-341 is the first agent targeting the ubiquitin-mediated proteolytic system to be headed for human testing, according to ProScript Inc., the small firm in Cambridge, Mass., that developed the drug. Clinical trials at NCI and several medical centers could begin later this summer if the Food and Drug Administra

Run a Search

ADVERTISEMENT